Jonathan Schultz

Co-­Founder and Managing Principal

Jonathan Schultz is Co-Founder and Managing Principal of Onyx Equities, LLC with John Saraceno, Jr.  Since its founding in 2004, Onyx has become one of the most diversified and active real estate investment, management, development, and property service organizations in the New York Metro market.

Jonathan leads the investor capital raising initiatives for Onyx, along with the fund-raising efforts for the Phalanx Funds. He also oversees the strategic planning, real estate technology development, and overall investment strategy for Onyx. His passions for both real estate and CRE technology investing have translated into a creative and innovative vision that has made Onyx unique among real estate developers and transformed nearly every aspect of the company’s operations.

An avid Podcaster, public speaker, and blogger, Jonathan has helped foster a new culture of tech savviness and awareness throughout the New York Metro area’s commercial real estate industry. Through his Podcast, The Jon Schultz Podcast: The Myth of Overnight Success, Jonathan unpacks lessons from industry leaders who discuss their stories, failures and the way they “flipped the script” to create success; emphasizing that success is never really overnight.

Jonathan is a graduate of Syracuse University. He is Chairman of the Board of the Big Apple Chapter of YPO, the premiere network of chief executives and business leaders, Chairman of the Board of the Riverview Medical Center Foundation, which serves Hackensack Meridian Health Network, serves on the board of NAIOP, the Commercial Real Estate Development Association, and is Chairman of the Innovation Committee, for TechUnited. Jonathan has sat on the boards of both publicly traded and private technology companies, and is a proud member of Mindaligned, which is a collective impact initiative to create arts-engaged schools. Jonathan is also a recipient of the Award of Courage Humanitarian Award for raising significant funds for Memorial Sloan-Kettering Cancer Center.